UnitedHealth Group Inc (NYSE:UNH) – Investment analysts at Leerink Swann upped their FY2018 earnings per share estimates for shares of UnitedHealth Group in a research report issued to clients and investors on Wednesday. Leerink Swann analyst A. Gupte now forecasts that the healthcare conglomerate will post earnings of $12.60 per share for the year, up from their prior forecast of $10.80. Leerink Swann currently has a “Outperform” rating on the stock. Leerink Swann also issued estimates for UnitedHealth Group’s FY2019 earnings at $14.40 EPS and FY2020 earnings at $16.50 EPS.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter last year, the business posted $2.11 EPS. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis.
Shares of UnitedHealth Group (NYSE UNH) opened at $243.35 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. UnitedHealth Group has a twelve month low of $156.49 and a twelve month high of $244.35. The firm has a market capitalization of $235,290.00, a price-to-earnings ratio of 22.72, a P/E/G ratio of 1.42 and a beta of 0.66.
In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. Insiders have sold a total of 33,655 shares of company stock worth $7,469,083 over the last ninety days. Company insiders own 0.89% of the company’s stock.
Several hedge funds have recently bought and sold shares of UNH. Covenant Asset Management LLC raised its position in shares of UnitedHealth Group by 2.7% in the 2nd quarter. Covenant Asset Management LLC now owns 7,185 shares of the healthcare conglomerate’s stock worth $1,332,000 after acquiring an additional 190 shares in the last quarter. ETF Portfolio Partners Inc. bought a new position in shares of UnitedHealth Group in the 2nd quarter worth about $206,000. Central Bank & Trust Co. raised its position in shares of UnitedHealth Group by 0.8% in the 2nd quarter. Central Bank & Trust Co. now owns 17,992 shares of the healthcare conglomerate’s stock worth $3,336,000 after acquiring an additional 134 shares in the last quarter. Johanson Financial Advisors Inc. raised its position in shares of UnitedHealth Group by 4.4% in the 2nd quarter. Johanson Financial Advisors Inc. now owns 6,802 shares of the healthcare conglomerate’s stock worth $1,264,000 after acquiring an additional 285 shares in the last quarter. Finally, Appleton Partners Inc. MA raised its position in shares of UnitedHealth Group by 1.1% in the 2nd quarter. Appleton Partners Inc. MA now owns 29,919 shares of the healthcare conglomerate’s stock worth $5,548,000 after acquiring an additional 339 shares in the last quarter. 86.09% of the stock is owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.